在亚太地区倡导糖尿病
Noriko Kodani1, Asuka Kato2, Moon-Kyu Lee3
1Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
Journal of diabetes investigation
|May 27, 2025
概括
糖尿病管理是具有挑战性的,因为耻辱和不平等的护理机会. 这项研究强调了亚太地区的倡导努力,以改善糖尿病患者 (PWD) 的生活质量和健康平等.
科学领域:
- 内分泌学和代谢性疾病
- 公共卫生和卫生政策
- 社会科学和人文学科 社会科学和人文学科
背景情况:
- 糖尿病带来了终身管理的挑战,经常伴随着持续的社会误解和耻辱.
- 糖尿病患者 (PWD) 在生活的各个方面面临歧视,并面临巨大的经济负担.
- 与糖尿病相关的耻辱会对自尊,自我照顾和临床结果产生负面影响,需要强有力的宣传.
研究的目的:
- 解决PWD所面临的挑战,包括耻辱和医疗保健准入方面的差异.
- 探索和分享有关亚太国家倡导运动的信息.
- 加强区域合作,改善残疾人的生活质量和全球健康公平.
主要方法:
- 审查现有文献和信息共享,来自亚太地区的选定国家.
- 对糖尿病管理,获取药物和技术的现状进行分析.
- 检查澳大利亚,中国,韩国,印度尼西亚和日本的宣传工作和倡议.
主要成果:
- 在亚太地区获得基本糖尿病药物和技术 (例如胰岛素,CGM,胰岛素) 存在显著差异.
- 对PWD的耻辱是普遍存在的,导致社会,教育和职业困难.
- 在研究的国家正在进行不同级别的宣传工作,以打击耻辱和改善护理.
结论:
- 宣传对于减轻糖尿病的负担和打击耻辱至关重要.
- 国际合作和相互理解对于加强糖尿病护理和实现健康公平至关重要.
- 加强亚太地区的宣传工作可以为全球倡议做出贡献,以改善PWD的健康结果.
相关概念视频
Diabetes: Management and Pharmacotherapy
412
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
412
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes: Symptoms, Diagnosis, and Complications
715
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
715
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Pathophysiology of Diabetes
1.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
310
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
310


